Edwards Lifesciences (EW) Financial Forecast Calculator
Interactive 5-year forecast and DCF for Edwards Lifesciences. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Edwards Lifesciences’s most recent SEC filings.
Assumptions
Need this as an Excel model?
Keep iterating on the Edwards Lifesciences forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.
Other Healthcare forecasts
Run the same calculator on a peer.
Frequently asked
What does Edwards Lifesciences do?+
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease. The company develops and manufactures tissue replacement heart valves and repair products, operating as a pure-play structural heart innovator following the divestiture of its Critical Care business.
How does Edwards Lifesciences generate its revenue?+
Edwards Lifesciences generates approximately 75% of its revenue from Transcatheter Aortic Valve Replacement (TAVR) products, with Surgical Structural Heart contributing about 18%, and Transcatheter Mitral and Tricuspid Therapies (TMTT) around 7%. Revenue growth is driven by direct sales forces and clinical trial data that encourage physician adoption.
What is Edwards Lifesciences' capital expenditure strategy?+
Edwards Lifesciences typically allocates 3% to 5% of its revenue to capital expenditures, with 70% of this investment directed towards growth initiatives. Major programs include expanding cleanroom manufacturing facilities in Costa Rica and Ireland to support new products like TMTT and RESILIA.
What is the purpose of the Edwards Lifesciences financial model?+
The financial model provides a comprehensive equity valuation and scenario planning tool for equity research analysts. It is designed to evaluate Edwards Lifesciences' standalone growth trajectory and margin expansion potential following the divestiture of its Critical Care business.
Is there a downloadable financial model available for Edwards Lifesciences?+
Yes, an Excel financial model for Edwards Lifesciences is available for download. This model offers a detailed framework for analyzing the company's financial performance and future projections over a forecast horizon of FY2026–FY2030.
What is Edwards Lifesciences' working capital profile?+
Edwards Lifesciences maintains a positive net working capital, typically representing 20% to 25% of its revenue. This profile is characterized by high inventory levels, which are necessary for the biological tissue processing and global distribution required for its medical devices.
Have more financial modelling questions? Contact us
